MedPath

JAMP LENALIDOMIDE

JAMP LENALIDOMIDE

Approved
DIN Number

02506157

Drug Class

Human

Market Date

Feb 2, 2022

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02506157
AIG Number0152422002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX04 LENALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LENALIDOMIDEActive
Strength: 10 MG
Monograph: LENALIDOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.